Bolt Biotherapeutics (BOLT) Balance Sheet: Assets & Liabilities

Bolt Biotherapeutics (BOLT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Bolt Biotherapeutics reported total assets of $56.75M and total liabilities of $30.24M. Shareholders' equity was $26.50M, down 53.7% from $57.20M a year earlier. Total debt stood at $22.96M against $27.50M in cash and short-term investments, a net cash position of $4.55M. That puts debt-to-equity at 0.87, compared with 0.44 a year earlier.

Bolt Biotherapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Bolt Biotherapeutics, Inc. (BOLT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	11.70	7.21	10.81	9.24	27.38	5.54	5.54	34.83	13.63
Short-Term Investments	15.80	40.12	91.38	159.64	158.84	17.30	17.30	0.00	0.00
Cash & Short-Term Investments	27.51	47.32	102.19	168.89	186.22	22.84	22.84	34.83	13.63
Accounts Receivable	0.97	0.81	0.60	0.00	0.20	0.00	-	0.30	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Other Current Assets	2.76	3.49	3.52	3.86	2.94	2.52	2.52	0.77	0.47
Total Current Assets	30.26	50.81	105.71	172.75	189.16	25.36	25.36	35.90	14.10
Non-Current Assets
Property, Plant & Equipment (Net)	20.48	24.90	24.08	28.53	30.60	16.38	16.35	11.52	1.44
Long-Term Investments	4.34	22.88	26.41	23.94	85.35	0.00	-	0.58	0.00
Other Non-Current Assets	1.68	1.04	3.59	2.59	2.61	4.80	2.47	0.45	0.43
Total Non-Current Assets	26.49	48.82	54.08	55.06	118.56	21.18	-	12.55	1.88
Total Assets	56.75	99.63	159.78	227.81	307.72	46.54	46.54	48.45	15.98
Current Liabilities
Accounts Payable	1.44	1.51	2.99	3.59	3.57	1.60	1.60	2.10	0.89
Short-Term Debt	2.83	2.25	2.78	2.39	2.50	1.50	-	3.10	0.04
Accrued Liabilities	3.72	9.08	12.49	15.14	12.38	-	6.66	-	-
Deferred Revenue	0.45	3.02	2.20	1.99	2.87	1.50	1.50	0.60	0.00
Other Current Liabilities	3.72	0.74	12.49	15.14	12.38	6.66	-	2.87	1.82
Total Current Liabilities	8.44	15.86	20.46	23.12	21.33	11.26	11.26	8.66	2.76
Non-Current Liabilities
Long-Term Debt	20.13	22.96	17.44	20.22	21.85	9.38	-	7.09	0.00
Other Non-Current Liabilities	1.68	3.62	9.15	0.04	14.42	130.85	0.33	77.58	29.16
Total Non-Current Liabilities	21.81	26.58	26.59	33.18	36.27	140.23	-	85.64	29.16
Total Liabilities	30.24	42.43	47.04	56.30	57.60	151.49	20.97	94.29	31.92
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Retained Earnings	-460.78	-427.40	-364.29	-295.09	-206.99	-108.40	-108.40	-47.67	-17.18
Accumulated Other Comprehensive Income	-0.02	0.10	0.04	-0.92	-0.32	0.00	-	0.00	0.00
Additional Paid-in Capital	487.31	484.50	476.99	467.51	457.43	3.45	-	-75.68	-27.13
Shares Outstanding	1.92	1.92	1.91	1.89	1.87	-	-	-	-
Total Stockholders' Equity	26.51	57.20	112.74	171.51	250.12	-104.95	25.57	-45.85	-15.94
Total Liabilities & Equity	56.75	99.63	159.78	227.81	307.72	46.54	-	48.45	15.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bolt Biotherapeutics Balance Sheet

How much debt does Bolt Biotherapeutics have?

Bolt Biotherapeutics had total debt of $22.96M as of Dec 31, 2025, against $27.50M in cash and short-term investments. Its debt-to-equity ratio was 0.87. Total debt was $25.21M a year earlier.

What are Bolt Biotherapeutics's total assets?

Bolt Biotherapeutics reported total assets of $56.75M as of Dec 31, 2025, down 43.0% from $99.63M a year earlier. Total liabilities were $30.24M.

What is Bolt Biotherapeutics's shareholders' equity?

Bolt Biotherapeutics's shareholders' equity was $26.50M as of Dec 31, 2025, or about $13.80 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition